# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.wsj.com/health/healthcare/medicare-will-recalculate-quality-ratings-of-medicare-advantage-plans-eebee409?mod=latest...
Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:HUM) with a Neutral and maintains $360 price target.
Baird analyst Michael Ha initiates coverage on Humana (NYSE:HUM) with a Neutral rating and announces Price Target of $374.
UnitedHealth Group Inc. (NYSE: UNH) saw its shares decline significantly following remarks made by CEO Andrew Witty at the Bern...
CVS Health seeks a private equity partner to fund the expansion of Oak Street Health, acquired for $10.6 billion. This joint ve...
Hedge funds are looking for high-return opportunities beyond the mega-cap tech giants preferring to focus on cyclical sectors a...